These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5573051)

  • 1. [Hemodynamics and excretory function of the kidney during furosemide and diazoxide administration. A contribution to the regulation of renin activity].
    Ganten D; Meurer KA; Kaufmann W
    Med Welt; 1971 Apr; 16():663-5. PubMed ID: 5573051
    [No Abstract]   [Full Text] [Related]  

  • 2. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of a single intravenous injection of diazoxide in patients with and without secondary aldosteronism].
    Schröder K; Wedler B; Börner H; Teichmann G; Rostock G; Riethling AK; Eckermann P; Schwebke A
    Z Gesamte Inn Med; 1977 Aug; 32(15):367-71. PubMed ID: 919654
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diazoxide and furosemide in the treatment of hypertensive emergencies (author's transl)].
    Duraković Z; Bakran V; Vrhovac B; Gjurasin M
    Lijec Vjesn; 1978 Apr; 100(4):244-8. PubMed ID: 672387
    [No Abstract]   [Full Text] [Related]  

  • 5. Aggressive drug therapy in accelerated hypertension.
    Finnerty FA
    Am J Nurs; 1974 Dec; 74(12):2176-80. PubMed ID: 4497426
    [No Abstract]   [Full Text] [Related]  

  • 6. Body electrolytes, renin-angiotensin system and aldosterone secretion in essential hypertension.
    Borghetti A; Bruschi G; Biggi A; Coruzzi P; Novarini A
    Panminerva Med; 1981; 23(2):105-14. PubMed ID: 7033892
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of renin secretion by various methods: optional results with hydrochlorothiazide.
    Traub YM; Nemes LM; Aloof S; Rosenfeld JB
    Int Urol Nephrol; 1976; 8(3):247-55. PubMed ID: 1002400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
    Pedersen EB
    Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of prostaglandins in the hemodynamic and tubular effects of furosemide.
    Gerber JG
    Fed Proc; 1983 Apr; 42(6):1707-10. PubMed ID: 6403387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationship between renal prostaglandin E, renin, and renal vascular tone in conscious dogs.
    Zimmerman BG; Mommsen C; Kraft E
    Adv Prostaglandin Thromboxane Res; 1980; 7():1153-7. PubMed ID: 6989185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of furosemide, captopril and indometacin on the renin-angiotensin system and the renal prostaglandins in anesthetized neonatal piglets.
    Joppich R; Weyer P; Eife R
    Arzneimittelforschung; 1995 Jul; 45(7):822-5. PubMed ID: 8573231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in plasma volume and electrolytes after treatment of therapy-resistant hypertension with diazoxide and furosemide].
    Kiesewetter R; Cebulla P; Herrmann RM; Stoll W
    Z Gesamte Inn Med; 1981 Sep; 36(17):627-30. PubMed ID: 7345809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of arterial hypertension in elderly patients].
    Halawa B
    Wiad Lek; 1981 Aug; 34(16):1357-62. PubMed ID: 7041432
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renal hemodynamic and functional changes induced with thyrocalcitonin].
    Zucchelli P; Fusaroli M; Sasdelli M
    Minerva Nefrol; 1969; 16(3):246-8. PubMed ID: 5356054
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of peripheral plasma renin activity (PRA) to furosemide stimulation; reduction of the renal parenchyma as a limiting factor.
    Zabka J; Stríbrná J; Rotnáglová Z
    Physiol Bohemoslov; 1981; 30(5):397-403. PubMed ID: 6459589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent cardiovascular, renal, and endocrine effects of furosemide in conscious lambs.
    Patel A; Smith FG
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1101-7. PubMed ID: 9365820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of diazoxide with frusemide, spironolactone, and acetylsalicylic acid in a patient with hyperinsulinism of Infancy and Fallot tetralogy.
    Alexander S; Anazodo A; Hussain K
    Eur J Pediatr; 2003 Nov; 162(11):806-7. PubMed ID: 13680383
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of benzothiazepine derivative (CRD-401) on blood pressure, excretion of electrolytes, and plasma renin activity.
    Funyu T; Nigawara K; Ohno K; Hamada W; Yagihashi Y
    Clin Ther; 1981; 3(6):456-66. PubMed ID: 7020940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the angiotensin converting enzyme (ACE) inhibitor, captopril, on the cardiovascular, endocrine, and renal responses to furosemide in conscious lambs.
    de Wildt SN; Smith FG
    Can J Physiol Pharmacol; 1997 Apr; 75(4):263-70. PubMed ID: 9196851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.